Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1993 Aug;37(8):1593–1598. doi: 10.1128/aac.37.8.1593

WIN 54954 treatment of mice infected with a diabetogenic strain of group B coxsackievirus.

D M See 1, J G Tilles 1
PMCID: PMC188025  PMID: 8215268

Abstract

The therapeutic efficacy of an experimental antiviral agent, WIN 54954, was evaluated in a mouse model in which infection by coxsackievirus B4 (CVB4) strain E2 was followed by diabetes mellitus. Male CD1 mice (age, 5 weeks) were inoculated with 10(4) PFU of CVB4. WIN 54954 was administered orally via gavage tube in a dose of either 5 or 50 mg/kg of body weight per day. Treatment was initiated on the day of inoculation and was continued for 10 days. Control animals received the xanthan gum carrier only. At 3 days postinoculation (p.i.), the mean titer of virus in the pancreas was found to be significantly lower in both the high-dose (P < 0.001) and low-dose (P < 0.05) treatment groups compared with that in the controls. Furthermore, islet histologic abnormalities were significantly less common in the high-dose group (P < 0.02) than in the controls. At 7 weeks p.i., both fasting and 1-h postprandial glucose levels in blood were significantly lower for both the high-dose (P < 0.001) and the low-dose (P < 0.01) treatment groups than in controls. The proportion of mice with persistent viral RNA in the pancreas at this time, as detected by polymerase chain reaction, was significantly reduced in the high-dose treatment group (4 of 11 mice) compared with that in the controls (7 of 8 mice). When mice received 50 mg of WIN 54954 per kg daily beginning at either 48 or 72 h postinoculation, the titers in the pancreas were again significantly reduced at 3 days p.i. compared with those in the controls (P < 0.01 and P < 0.05, respectively). Thus, WIN 54954 effectively reduces virus replication and islet histologic changes acutely and decreases, at 7 weeks, both the metabolic alteration associated with diabetes mellitus and the incidence of detectable viral RNA in the pancreas.

Full text

PDF
1593

Images in this article

1596Image
on p.1596

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baek H. S., Yoon J. W. Role of macrophages in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J Virol. 1990 Dec;64(12):5708–5715. doi: 10.1128/jvi.64.12.5708-5715.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baekkeskov S., Dyrberg T., Lernmark A. Autoantibodies to a 64-kilodalton islet cell protein precede the onset of spontaneous diabetes in the BB rat. Science. 1984 Jun 22;224(4655):1348–1350. doi: 10.1126/science.6374896. [DOI] [PubMed] [Google Scholar]
  3. Bendelac A., Carnaud C., Boitard C., Bach J. F. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. J Exp Med. 1987 Oct 1;166(4):823–832. doi: 10.1084/jem.166.4.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chatterjee N. K., Haley T. M., Nejman C. Functional alterations in pancreatic beta cells as a factor in virus-induced hyperglycemia in mice. J Biol Chem. 1985 Oct 15;260(23):12786–12791. [PubMed] [Google Scholar]
  5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  6. Craighead J. E. The role of viruses in the pathogenesis of pancreatic disease and diabetes mellitus. Prog Med Virol. 1975;19:161–214. [PubMed] [Google Scholar]
  7. Cudworth A. G., White G. B., Woodrow J. C., Gamble D. R., Lendrum R., Bloom A. Aetiology of juvenile-onset diabetes. A prospective study. Lancet. 1977 Feb 19;1(8008):385–388. doi: 10.1016/s0140-6736(77)92602-2. [DOI] [PubMed] [Google Scholar]
  8. Fox M. P., Otto M. J., McKinlay M. A. Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug. Antimicrob Agents Chemother. 1986 Jul;30(1):110–116. doi: 10.1128/aac.30.1.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Frisk G., Friman G., Tuvemo T., Fohlman J., Diderholm H. Coxsackie B virus IgM in children at onset of type 1 (insulin-dependent) diabetes mellitus: evidence for IgM induction by a recent or current infection. Diabetologia. 1992 Mar;35(3):249–253. doi: 10.1007/BF00400925. [DOI] [PubMed] [Google Scholar]
  10. Gerling I., Baekkeskov S., Lernmark A. Islet cell and 64K autoantibodies are associated with plasma IgG in newly diagnosed insulin-dependent diabetic children. J Immunol. 1986 Dec 15;137(12):3782–3785. [PubMed] [Google Scholar]
  11. Gerling I., Nejman C., Chatterjee N. K. Effect of coxsackievirus B4 infection in mice on expression of 64,000-Mr autoantigen and glucose sensitivity of islets before development of hyperglycemia. Diabetes. 1988 Oct;37(10):1419–1425. doi: 10.2337/diab.37.10.1419. [DOI] [PubMed] [Google Scholar]
  12. HALES C. N., RANDLE P. J. Immunoassay of insulin with insulin-antibody precipitate. Biochem J. 1963 Jul;88:137–146. doi: 10.1042/bj0880137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hartig P. C., Madge G. E., Webb S. R. Diversity within a human isolate of coxsackie B4: relationship to viral-induced diabetes. J Med Virol. 1983;11(1):23–30. doi: 10.1002/jmv.1890110104. [DOI] [PubMed] [Google Scholar]
  14. Huff J. C., Hierholzer J. C., Farris W. A. An "outbreak" of juvenile diabetes mellitus: consideration of a viral etiology. Am J Epidemiol. 1974 Oct;100(4):277–287. doi: 10.1093/oxfordjournals.aje.a112036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Karjalainen J., Martin J. M., Knip M., Ilonen J., Robinson B. H., Savilahti E., Akerblom H. K., Dosch H. M. A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N Engl J Med. 1992 Jul 30;327(5):302–307. doi: 10.1056/NEJM199207303270502. [DOI] [PubMed] [Google Scholar]
  16. Kaufman D. L., Erlander M. G., Clare-Salzler M., Atkinson M. A., Maclaren N. K., Tobin A. J. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest. 1992 Jan;89(1):283–292. doi: 10.1172/JCI115573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Like A. A., Anthony M., Guberski D. L., Rossini A. A. Spontaneous diabetes mellitus in the BB/W rat. Effects of glucocorticoids, cyclosporin-A, and antiserum to rat lymphocytes. Diabetes. 1983 Apr;32(4):326–330. doi: 10.2337/diab.32.4.326. [DOI] [PubMed] [Google Scholar]
  18. Like A. A., Kislauskis E., Williams R. R., Rossini A. A. Neonatal thymectomy prevents spontaneous diabetes mellitus in the BB/W rat. Science. 1982 May 7;216(4546):644–646. doi: 10.1126/science.7041259. [DOI] [PubMed] [Google Scholar]
  19. Like A. A., Rossini A. A., Guberski D. L., Appel M. C., Williams R. M. Spontaneous diabetes mellitus: reversal and prevention in the BB/W rat with antiserum to rat lymphocytes. Science. 1979 Dec 21;206(4425):1421–1423. doi: 10.1126/science.388619. [DOI] [PubMed] [Google Scholar]
  20. MacMillan D. R., Kotoyan M., Zeidner D., Hafezi B. Seasonal variation in the onset of diabetes in children. Pediatrics. 1977 Jan;59(1):113–115. [PubMed] [Google Scholar]
  21. Maclaren N., Schatz D., Drash A., Grave G. Initial pathogenic events in IDDM. Diabetes. 1989 Apr;38(4):534–538. doi: 10.2337/diab.38.4.534. [DOI] [PubMed] [Google Scholar]
  22. McKinlay M. A., Frank J. A., Jr, Benziger D. P., Steinberg B. A. Use of WIN 51711 to prevent echovirus type 9-induced paralysis in suckling mice. J Infect Dis. 1986 Oct;154(4):676–681. doi: 10.1093/infdis/154.4.676. [DOI] [PubMed] [Google Scholar]
  23. McKinlay M. A., Steinberg B. A. Oral efficacy of WIN 51711 in mice infected with human poliovirus. Antimicrob Agents Chemother. 1986 Jan;29(1):30–32. doi: 10.1128/aac.29.1.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Montgomery L. B., Loria R. M., Chinchilli V. M. Immunodeficiency as primary phenotype of diabetes mutation db. Studies with coxsackievirus B4. Diabetes. 1990 Jun;39(6):675–682. doi: 10.2337/diab.39.6.675. [DOI] [PubMed] [Google Scholar]
  25. Musiani M., Zerbini M., Gibellini D., Gentilomi G., Venturoli S., Gallinella G., Ferri E., Girotti S. Chemiluminescence dot blot hybridization assay for detection of B19 parvovirus DNA in human sera. J Clin Microbiol. 1991 Sep;29(9):2047–2050. doi: 10.1128/jcm.29.9.2047-2050.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Palmer J. P., Cooney M. K., Crossley J. R., Hollander P. H., Asplin C. M. Antibodies to viruses and to pancreatic islets in nondiabetic and insulin-dependent diabetic patients. Diabetes Care. 1981 Sep-Oct;4(5):525–528. doi: 10.2337/diacare.4.5.525. [DOI] [PubMed] [Google Scholar]
  27. Richter W., Endl J., Eiermann T. H., Brandt M., Kientsch-Engel R., Thivolet C., Jungfer H., Scherbaum W. A. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8467–8471. doi: 10.1073/pnas.89.18.8467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rotbart H. A. Enzymatic RNA amplification of the enteroviruses. J Clin Microbiol. 1990 Mar;28(3):438–442. doi: 10.1128/jcm.28.3.438-442.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. See D. M., Tilles J. G. Treatment of Coxsackievirus A9 myocarditis in mice with WIN 54954. Antimicrob Agents Chemother. 1992 Feb;36(2):425–428. doi: 10.1128/aac.36.2.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Smith L. J., Braylan R. C., Nutkis J. E., Edmundson K. B., Downing J. R., Wakeland E. K. Extraction of cellular DNA from human cells and tissues fixed in ethanol. Anal Biochem. 1987 Jan;160(1):135–138. doi: 10.1016/0003-2697(87)90623-3. [DOI] [PubMed] [Google Scholar]
  31. Svenningsen A., Dyrberg T., Gerling I., Lernmark A., Mackay P., Rabinovitch A. Inhibition of insulin release after passive transfer of immunoglobulin from insulin-dependent diabetic children to mice. J Clin Endocrinol Metab. 1983 Dec;57(6):1301–1304. doi: 10.1210/jcem-57-6-1301. [DOI] [PubMed] [Google Scholar]
  32. Szopa T. M., Ward T., Dronfield D. M., Portwood N. D., Taylor K. W. Coxsackie B4 viruses with the potential to damage beta cells of the islets are present in clinical isolates. Diabetologia. 1990 Jun;33(6):325–328. doi: 10.1007/BF00404634. [DOI] [PubMed] [Google Scholar]
  33. Todd J. A., Acha-Orbea H., Bell J. I., Chao N., Fronek Z., Jacob C. O., McDermott M., Sinha A. A., Timmerman L., Steinman L. A molecular basis for MHC class II--associated autoimmunity. Science. 1988 May 20;240(4855):1003–1009. doi: 10.1126/science.3368786. [DOI] [PubMed] [Google Scholar]
  34. Todd J. A. Genetic control of autoimmunity in type 1 diabetes. Immunol Today. 1990 Apr;11(4):122–129. doi: 10.1016/0167-5699(90)90049-f. [DOI] [PubMed] [Google Scholar]
  35. Wagenknecht L. E., Roseman J. M., Herman W. H. Increased incidence of insulin-dependent diabetes mellitus following an epidemic of Coxsackievirus B5. Am J Epidemiol. 1991 May 15;133(10):1024–1031. doi: 10.1093/oxfordjournals.aje.a115811. [DOI] [PubMed] [Google Scholar]
  36. Webb S. R., Loria R. M., Madge G. E., Kibrick S. Susceptibility of mice to group B coxsackie virus is influenced by the diabetic gene. J Exp Med. 1976 May 1;143(5):1239–1248. doi: 10.1084/jem.143.5.1239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wee L., Liu P., Penn L., Butany J. W., McLaughlin P. R., Sole M. J., Liew C. C. Persistence of viral genome into late stages of murine myocarditis detected by polymerase chain reaction. Circulation. 1992 Nov;86(5):1605–1614. doi: 10.1161/01.cir.86.5.1605. [DOI] [PubMed] [Google Scholar]
  38. Woods M. G., Diana G. D., Rogge M. C., Otto M. J., Dutko F. J., McKinlay M. A. In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug. Antimicrob Agents Chemother. 1989 Dec;33(12):2069–2074. doi: 10.1128/aac.33.12.2069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Yoon J. W., Austin M., Onodera T., Notkins A. L. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med. 1979 May 24;300(21):1173–1179. doi: 10.1056/NEJM197905243002102. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES